Suzanne Lentzsch, MD

Suzanne Lentzsch, MD Specialties: Medical Oncology, Hematology

Book Online
Suzanne Lentzsch, MD
Specialties: Medical Oncology, Hematology
phone icon
checkmark iconAccepting new patients
"
One of America's Top Doctors - Castle Connolly Top Doctors
Rated one of New York Magazine's Best Doctors
Book Online

Address

161 Fort Washington Avenue
New York, NY 10032
US

doctor iconDoctor Office Hours

Store Hours:

Day of the WeekHours
Monday9:00 AM - 5:00 PM
Tuesday9:00 AM - 5:00 PM
Wednesday9:00 AM - 5:00 PM
Thursday9:00 AM - 5:00 PM
Friday9:00 AM - 5:00 PM
SaturdayClosed
SundayClosed

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • AETNA
  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • Capital District Physician Health Plan
  • CIGNA
  • Emblem/GHI
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • United Health Care
  • VNSNY CHOICE SelectHealth
  • WellCare

bookonline iconbookonline icon
Book Online

Book an Appointment Online

Select the type of appointment you would like to schedule with this provider. Please note: If you would like to schedule a video visit, but will not be in New York State at the time of the visit, you will need to contact this provider’s office to determine where and how the provider may be able to see you.
Please select an appointment type before proceeding.

Time

Select your preferred date and time for your appointment. To see appointments for dates further in the future, update the date to start your search. If this provider has appointments available at more than one location, you can select a specific location to view the appointments that are available only at that location.

about iconabout icon
About Suzanne Lentzsch, MD

Dr. Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York. She is at New York Presbyterian Hospital/ Columbia University Medical Center. After receiving her degrees from the Humboldt University/ Charité Berlin, Germany, she completed her residency and fellowship at Humboldt University. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr Kenneth Anderson at the Dana-Farber Cancer Ins...
Dr. Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York. She is at New York Presbyterian Hospital/ Columbia University Medical Center. After receiving her degrees from the Humboldt University/ Charité Berlin, Germany, she completed her residency and fellowship at Humboldt University. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, MA, USA. Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia. Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation "Black Swan Research Initiative" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Lawrence Hospital

Expertise

  • Amyloidosis

  • Bone Marrow Transplant

  • MGUS (Monoclonal Gammopathy of Unknown Significance)

  • Multiple Myeloma

  • Peripheral Stem Cell Transplant

  • POEMS Syndrome

  • Waldenstrom's Disease

Languages Spoken

  • German

awards iconawards icon
Awards

  • 2005 - Research Day Awardee, Junior Faculty Category, University of Pittsburgh School of Medicine, Department of Medicine Third Annual Research Day
  • 2009 - UPCI Junior Scholar Award in Clinical Cancer Research
  • 2012 - ASH Advocacy Leadership Institute
  • 2012 - Japanese Society of Hematology Appreciation Award
  • 2012/13 - “Leukemia Diploma For a selection of worthy articlesin 2012/2013” by Editor in Chief, Leukemia
  • 2014 - Leukemia Lymphoma Society, Woman of the year Candidate
  • 2014/15 - MMRF Laugh for Life Honorary Chair